Nachrichten und Videos - LIFE SCIENCE REIT ORD GBP0.01

GOTHENBURG, SE / ACCESSWIRE / November 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 27, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at the Redeye Technology & Life Science Day 2024 on Tuesday, December 3, 2024, in Stockholm, Sweden. Kristina Torfgård, CEO, and Nicholas Waters, EVP, Head of R&D, will participate in the...

STOCKHOLM, SWEDEN / ACCESSWIRE / November 26, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company is participating at Redeye Life Science Day 2024 on December 3 at 13:00 CET, where CEO Martin Jönsson and CSO Johan Sandin will participate in a Q&A and answer questions about the latest...

Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus PR Newswire PASADENA, Calif., Nov. 21, 2024 PASADENA, Calif. , Nov. 21, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, today...

GOTHENBURG, SWEDEN / ACCESSWIRE / November 13, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 13, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announces that CEO Kristina Torfgård will present IRLAB to potential partners and specialist investors in life science at the seventh edition of BioStock Life Science Summit. The event will take place on November 20-21 in Lund,...

EQS-News: TVM Life Science Management GmbH / Key word(s): Conference DISCOVER THE POWER OF AI IN BIOPHARMA: TVM TO HOST THOUGHT-PROVOKING SESSIONS AT BIO-EUROPE 2024 30.10.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. DISCOVER THE POWER OF AI IN BIOPHARMA: TVM TO HOST THOUGHT-PROVOKING SESSIONS AT BIO-EUROPE 2024 Munich, Germany and Montreal, Quebec, Canada (October 30, 2024) – TVM Capital Life Science (“TVM”), a leading international venture...

HONG KONG, Oct 25, 2024 - (ACN Newswire) - The 17th "C.C. Tan Life Science Award" ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the "C.C. Tan Life Science Industrialization Award". C.C. Tan Life Science Award has the highest honor as "the Chinese Nobel" in life science. In the context of the comprehensive construction of Chinese-style modernization and the development of new productivity, this...

EQS-News: Serum Life Science Europe GmbH / Key word(s): Regulatory Approval/Preliminary Results SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY – a novel Tuberculosis Skin Test in Europe 23.10.2024 / 10:09 CET/CEST The issuer is solely responsible for the content of this announcement. SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY ® – a novel Tuberculosis Skin Test in Europe SIILTIBCY ® is poised to be the first skin test...

EQS-News: Serum Life Science Europe GmbH / Schlagwort(e): Zulassungsgenehmigung/Vorläufiges Ergebnis Neuartiger Tuberkulose-Hauttest: SLS Europe und Bilthoven Biologicals erhalten positive Empfehlung des Ausschusses für Humanarzneimittel (CHMP) zur zentralen Zulassung von SIILTIBCY 23.10.2024 / 10:09 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Neuartiger Tuberkulose-Hauttest: SLS Europe und Bilthoven Biologicals erhalten positive Empfehlung des...

VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies PR Newswire NASHVILLE, Tenn. and CONROE, Texas, Oct. 15, 2024 Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE, Texas , Oct. 15, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and VGXI, Inc. ,...

BOSTON, MA / ACCESSWIRE / September 24, 2024 / Longwood Healthcare Leaders will convene top biopharmaceutical executives for two days of discussion and networking at Boston CEO, a leading industry meeting co-hosted by Christoph Westphal, John Maraganore, Ted Love, Marcus Schindler, Susan Hockfield, and Mathai Mammen, held at the Mandarin Oriental Hotel, Boston, October 28-29, 2024. Longwood Healthcare Leaders Logo Longwood Healthcare Leaders Logo The networking and discussion forum focuses on a...

Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment PR Newswire NANJING, China, Sept. 16, 2024 NANJING , China , Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through its innovative products. The study, which focuses on how mutant IDH1 inhibition activates tumor immunity by inducing double-stranded DNA (dsDNA) sensing,...

Alexandria Real Estate Equities, Inc. Honored for Sustainable Design in Nareit's Inaugural Sustainability Impact Awards, Highlighting Its Longstanding Operational Excellence at the Vanguard and Heart of the Life Science Industry PR Newswire PASADENA, Calif., Sept. 12, 2024 Alexandria's prestigious recognition among Nareit's first cohort of honorees demonstrates the company's continued leadership in advancing innovative sustainable design strategies for its mission-critical Labspace ®...

EQS-News: TVM Life Science Management GmbH / Key word(s): Conference TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI EUROPE ’24 EMERGING MEDTECH SUMMIT 2024 11.09.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI EUROPE ’24 EMERGING MEDTECH SUMMIT 2024 TVM and Portfolio Companies Showcase Transformative Partnerships and Industry Trends in Panel discussions and Presentations Munich, Germany and Montreal,...

GOTHENBURG, SE / ACCESSWIRE / September 06, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 6, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will give a presentation at the event Investing in life science: From seed to success, in Stockholm on September 12, 2024. The event is hosted by Biostock and Vator Securities at World Trade Center...

FAIRFIELD, CT / ACCESSWIRE / July 30, 2024 / Envision Pharma Group (Envision) announced today the appointment of Bill Shirey as President of Life Science Commercialization. Overseeing the Two Labs and Riparian brands, Bill will focus on enhancing Envision's commercialization and compliance solutions, delivering customized strategies that help bring pharmaceutical products to market and maintain compliance across the product lifecycle through industry expertise, integration, and strategic...

Alexandria Real Estate Equities, Inc. Releases 2023 Corporate Responsibility Report Highlighting Its Longstanding Leadership at the Vanguard and Heart of the Life Science Industry PR Newswire PASADENA, Calif., June 28, 2024 Alexandria announces that a recently completed large-scale solar farm is now supplying renewable power to meet 100% of its Greater Boston region's electricity load through a long-term power purchase agreement Alexandria joined Moderna and the Massachusetts governor on June 26...

PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024. As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% of outstanding common stock were voted representing a quorum. Shareholders approved the election of two Class B Trustees to the Board to serve until 2027 Annual Meeting by the following votes: Number of Votes...

Alexandria Real Estate Equities, Inc. Announces Long-Term 127,382 RSF Lease With Top 20 Pharmaceutical Company and Longstanding Credit Tenant for New R&D Life Science Center at the SD Tech by Alexandria Mega Campus in San Diego PR Newswire PASADENA, Calif., June 25, 2024 PASADENA, Calif. , June 25, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses...

As Chief Operating Officer of ILC Dover, Scott Watson’s track record and operational expertise positions Ingersoll Rand for the next level of growth within life sciences Thoughtful succession plan positions company for seamless leadership transition DAVIDSON, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, today announced Scott Watson, former chief operating officer of ILC...

Abu Dhabi is Underway to Become a Global Pharmaceutical and Life Science Distribution Hub PR Newswire ABU DHABI, UAE, June 7, 2024 ABU DHABI, UAE, June 7, 2024 /PRNewswire/ -- During BIO International Convention 2024 , The Department of Health – Abu Dhabi (DoH) , the regulator of the healthcare sector in the Emirate, and Abu Dhabi Investment Office (ADIO), Etihad Airways and AD Ports Group have signed a landmark Memorandum of Understanding (MoU) to strengthen Abu Dhabi's position as a global...